Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics

Date: Thursday, 25 February 2021 - Friday, 26 February 2021
Location: Virtual Conference

Conference Chairs

Michael Graner
Professor, University of Colorado Anschutz School of Medicine

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

My Mahoney
Professor and Vice Chair, Thomas Jefferson University

Alissa Weaver
Cornelius Vanderbilt Professor of Cell and Developmental Biology, Vanderbilt University Medical Center

Raghu Kalluri
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center

Fatah Kashanchi
Professor and Director of Research, Lab of Molecular Virology, George Mason University

Chris Baldwin
Chief Commercial Officer, Exopharm Ltd.

Dolores Di Vizio
Professor, Cedars Sinai Medical Center

Overview

SelectBIO EV-based Diagnostics, Delivery & Therapeutics 2021 Conference, February 25-26, 2021 Virtually Implemented in the US Eastern Time Zone brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas:

Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
Exosome/EV Engineering -- Engineered Exosomes for Delivery
Drug Delivery via Engineered Vesicles
Exosomes/EV-based Therapeutics Development
Exosomes/EVs-derived from Stem Cells and their Role in Regenerative Medicine

This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas:

Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
Role in Cancer and Various Disease Classes
Biomarker Potential for Diagnostics Development
Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development

The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

Conference Presentations and Content Organization

EV-based Diagnostics, Delivery and Therapeutics 2021
Circulating Biomarkers 2021

The Conference is Virtually Run and Powered by Zoom.
If you have not yet received your Zoom login credentials from SelectBIO, please contact Jeff Fan at J.Fan@selectbio.com

Agenda Topics

Engineered Exosomes and Extracellular Vesicles (EVs) for Drug Delivery
Engineering EVs as Biologic Drugs and Vaccines
Ex Vivo Production of Large Quantities of EVs for Therapeutics: Challenges and Opportunities
Exosomes-based Diagnostics/Liquid Biopsy Development

Diagnostics Markers Carried by Exosomes
Liquid Biopsy Enabled by Analyzing Exosome Biomarker Cargo

Exosomes/EVs-based Drug Delivery Approaches
Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
Stem Cell-based EVs for Regenerative Medicine

Mesenchymal Stem Cells (MSCs): EVs as a Mediator of Cell Therapy?

The Intersection of Exosomes and Viruses

Is there a Deep Connection Between Exosomes/EVs and Animal Viruses?

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Johnathon Anderson, Assistant Professor, University of California-Davis
Rachel DeRita, Director, Extracellular Vesicle Core Facility, University of Pennsylvania School of Veterinary medicine
Jean-Luc Fraikin, CEO, Spectradyne
Jack Keene, James B. Duke Professor, Duke University Medical Center
Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA
Aurelio Lorico, Professor of Pathology, Touro University Nevada School of Medicine
Leonid Margolis, Head, Section of Intercellular Interactions, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, NIH
John Nolan, CEO, Cellarcus Biosciences, Inc.
Haley Pugsley, Manager and Senior Scientist, Luminex Corporation
Zoltan Varga, Biological Nanochemistry Research Group, Research Centre for Natural Sciences (RCNS)

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2021-02-25 00:00:002021-02-26 00:00:00Europe/LondonExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and TherapeuticsExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in Virtual ConferenceVirtual ConferenceSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors

	Extracellular Vesicles (EVs) & Nanoparticles 2024: Diagnostics, Delivery, Therapeutics Location: Miami, Florida Date: 03/04/2024 - 04/04/2024

	Emerging Technologies & Paradigms for In Vitro Dx Europe 2024 Location: Rotterdam, The Netherlands Date: 18/03/2024 - 19/03/2024

	Emerging Technologies for Diagnostics - New Orleans 2024 Location: New Orleans Date: 26/09/2024 - 27/09/2024